Spots Global Cancer Trial Database for oncology
Every month we try and update this database with for oncology cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma | NCT00434161 | Multiple Myelom... | Palifermin befo... Placebo Palifermin befo... | 18 Years - 70 Years | Swedish Orphan Biovitrum | |
Understanding immunE-related toXicities by multifACeT Profiling | NCT05331066 | Oncology | 18 Years - | Royal Marsden NHS Foundation Trust | ||
Distracting Through Procedural Pain and Distress | NCT04892160 | Chronic Illness Hematologic Mal... Bone Marrow Tra... Oncology Sickle Cell Dis... | Guided Imagery Virtual Reality | 8 Years - 25 Years | Medical College of Wisconsin | |
PEWS Implementation in an LMIC Setting | NCT04180306 | Oncology | pediatric early... | 0 Years - 12 Years | Boston Children's Hospital | |
CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma | NCT05257590 | Hepatocellular ... Advanced Cancer | Nivolumab Injec... CVM-1118 | 18 Years - | TaiRx, Inc. | |
Integrated Care Pathway in Oncology (PASSION) | NCT04235556 | Colon Cancer Gastric Cancer Pancreatic Canc... Thoracic Neopla... Breast Cancer Ovarian Cancer Bladder Cancer Prostate Cancer | Care pathway un... | 18 Years - 80 Years | Assistance Publique - Hôpitaux de Paris | |
A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma | NCT02157636 | Multiple Myelom... | CPI-0610 | 18 Years - | Constellation Pharmaceuticals | |
A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma | NCT01472198 | Pancreatic Canc... | Simtuzumab Gemcitabine Placebo to matc... | 18 Years - | Gilead Sciences | |
The 1st Tumor CytokinoTherapy Database (TCTD-1) | NCT06222801 | Oncology | Tumor necrosis ... Interferon gamm... | 18 Years - 95 Years | OncoCareClinic 308 Ltd | |
Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma | NCT03837977 | Oncology Neuroendocrine ... | Liposomal Irino... Fluorouracil Folinic Acid Docetaxel | 18 Years - | The Christie NHS Foundation Trust | |
The ONCOCAMP Study | NCT06270602 | Oncology | Data collection... Data collection... | 18 Years - | National Cancer Institute, Naples | |
Impact of Radiation Therapy on Breast Conservation in DCIS | NCT02248662 | DCIS | 21 Years - | Dana-Farber Cancer Institute | ||
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer | NCT00393822 | Colon Cancer | palifermin placebo | 18 Years - | Amgen | |
Microbiota Transplant in Advanced Lung Cancer Treated With Immunotherapy | NCT04924374 | Lung Cancer | Microbiota Tran... anti PD1 therap... | 18 Years - | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | |
An Observational Study of the Prevalence of Patients Requiring Palliative Care in French Anti-cancer Centers. | NCT02479061 | Neoplasms Oncology | 18 Years - | Centre Leon Berard | ||
DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01) | NCT03384940 | Colorectal Neop... | DS-8201a | 18 Years - | Daiichi Sankyo | |
Study of a Predictor for Cervix Cancer | NCT01641484 | Cervix Cancer Oncology | local control a... | 18 Years - 65 Years | Centre Oscar Lambret | |
3-part Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EXS21546 | NCT04727138 | Oncology | EXS21546 Powder... EXS21546 Granul... Midazolam Food Effect Placebo Powder ... | 18 Years - 55 Years | Exscientia AI Limited | |
Risk Scoring Model for Endometrial Cancer | NCT03298100 | Oncology | Scoring model | 40 Years - | Ain Shams University | |
Developing and Implementing E-psychotherapy Program for Mental Health Challenges in Oncology and Palliative Care | NCT04664270 | Mental Health I... Depression Anxiety Palliative Care Oncology | e-CBT | 18 Years - 55 Years | Queen's University | |
PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers | NCT00136890 | Non-small-cell ... | PET Imaging | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
Sarah Cannon Outcomes Registry | NCT02356822 | Oncology | Patient registr... | 18 Years - | SCRI Development Innovations, LLC | |
A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study | NCT00115167 | Anemia Cancer | Placebo Darbepoetin alf... | 18 Years - | Amgen | |
Cope 360 App for Caregivers of Children With Cancer | NCT05112458 | Pediatric Cance... | Cope 360 mobile... Usual care | - | Indiana University | |
Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer | NCT00684294 | Carcinoma, Adva... | TGFβ2 Antisense... | 18 Years - | Mary Crowley Medical Research Center | |
Escape Room Game in Oncology Nursing | NCT06181058 | Oncology Education | escape room gam... | 18 Years - 40 Years | Ankara Yildirim Beyazıt University | |
A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies | NCT01943851 | Neoplasms | GSK525762 | 18 Years - | GlaxoSmithKline | |
Phase I Study of AT13148, a Novel AGC Kinase Inhibitor | NCT01585701 | Advanced Solid ... | AT13148 | 18 Years - | Cancer Research UK | |
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer | NCT06346782 | Pediatric Cance... Oncology Disruptive Beha... | Internet-Based ... | - | Johns Hopkins All Children's Hospital | |
A Study of ASP1951 in Subjects With Advanced Solid Tumors | NCT03799003 | Advanced Solid ... | ASP1951 pembrolizumab | 18 Years - | Astellas Pharma Inc | |
Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening | NCT04746872 | Human Papilloma... | Alinity m HR HP... | 25 Years - | Abbott Molecular | |
Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies | NCT00239239 | Non-Myeloid Mal... Anemia Cancer | Darbepoetin alf... | 18 Years - | Amgen | |
Epidemiology of Breast Cancer in Women Based on Diagnosis Data From Oncologists and Breast Surgeons in Algeria | NCT02733601 | Oncology Epidemiology Breast Cancer | NIS (Non Interv... | - | AstraZeneca | |
A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components | NCT02549222 | Transfusion Rel... | Standard of Car... | - | Cerus Corporation | |
Giving Information Systematically and Transparently in Lung and GI Cancer Phase 2 | NCT04179305 | Critical Illnes... Oncology Communication | Oncolo-GIST Usual Care Arm | 18 Years - | Weill Medical College of Cornell University | |
Creating an Innovative AI-based Technology TCRact for Designing and Optimizing T-cell Receptors (TCR) for Use in Cancer Immunotherapies | NCT04994093 | Colon Cancer Cancer | Collection of b... | 18 Years - | Ardigen | |
Pharmacogenomic-Guided Supportive Care in Hematopoietic Cell Transplantation | NCT04727827 | Hematopoietic C... Oncology | Pharmacogenomic... | 18 Years - | Wake Forest University Health Sciences | |
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas | NCT01231347 | Adenocarcinoma ... Advanced Solid ... Cancer Cancer of Pancr... Cancer of the P... Metastases Metastatic Canc... Metastatic Panc... Pancreas Cancer Pancreatic Canc... Bone Metastases Endocrine Cance... Oncology Oncology Patien... Solid Tumors Advanced Malign... | AMG 479 Placebo AMG 479 gemcitabine | 18 Years - | NantCell, Inc. | |
LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer | NCT02668913 | Epithelial Ovar... Peritoneal Canc... Fallopian Tube ... Gynaecological ... | Diagnostic anal... | 18 Years - | University of Leeds | |
Nutrition and Cancer Outcomes in Shaanxi Chemoradiotherapy | NCT06219083 | Cancer Chemoradiothera... Nutrition, Heal... Oncology Clinical Outcom... | 18 Years - | Health Science Center of Xi'an Jiaotong University | ||
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP) | NCT05615246 | Osteoarthritis ... Rheumatoid Arth... Oncology | 21 Years - | Exactech | ||
A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients | NCT06010342 | Solid Tumor | TL118 Capsule | 18 Years - | Teligene US | |
Patient-Empowered Mobile Technology in Hospitalized Patients (TRU-PAIN) | NCT02895841 | Pain | SMART app weara... | 8 Years - 80 Years | Duke University | |
Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel | NCT01668459 | Transitional Ce... | Cabazitaxel Best Supportive... | 18 Years - | University Hospital Birmingham NHS Foundation Trust | |
Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma | NCT04225429 | Epithelioid Sar... | Tazemetostat | 18 Years - | Ipsen | |
COVID-19 Detection Test in Oncology | NCT04367870 | Oncology | 18 Years - | UNICANCER | ||
Comparison to Psychological, Medical and Emotional Influencing Communication and Achievement Factors to Oncogenetics Tests | NCT03889171 | Cancer Colorectal Canc... Breast Cancer Ovarian Cancer | Behaviour | 18 Years - | University Hospital, Montpellier | |
Escape Room Game in Oncology Nursing | NCT06181058 | Oncology Education | escape room gam... | 18 Years - 40 Years | Ankara Yildirim Beyazıt University | |
Integrated Molecular Analysis of Cancer (IMAC) | NCT02078544 | Cancer | Integrated Mole... | 21 Years - | National University Hospital, Singapore | |
Effectiveness of an Individual Mindfulness-based Intervention for Cancer Patients in a Advanced Stage of the Disease and Their Relatives | NCT03492073 | Cancer | Emotional Suppo... Emotional Suppo... | 18 Years - | Instituto de Investigación Hospital Universitario La Paz | |
A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer | NCT02507544 | Carcinoma Advanced Cancer | TRX-818 capsule... | 18 Years - | TaiRx, Inc. | |
Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors | NCT01031719 | H1N1 Influenza ... Invasive Solid ... | adjuvanted A(H1... non-adjuvanted ... non-adjuvanted ... | 2 Years - 70 Years | Chiltern Pesquisa Clinica Ltda | |
Anemia and Red Blood Cells Transfusion in Oncological Surgery | NCT04101240 | Anemia Surgery Oncology | 18 Years - | University Hospital, Brest | ||
Cancer and Hearing Loss Related in Children | NCT02425397 | Cancer in Child... Hearing Loss | Genetic study Genetic study M... | 4 Years - | Assistance Publique - Hôpitaux de Paris | |
xPedite: A Study to Expedite DIPG and DMG Research | NCT06140719 | Oncology DIPG DMG | - | xCures | ||
Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer | NCT00323882 | Prostate Cancer Neoplasm Metast... | MDX-010 | 18 Years - | Bristol-Myers Squibb | |
A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa | NCT00119613 | Small Cell Lung... | placebo darbepoetin alf... | 18 Years - | Amgen | |
Tracing Brain Tumors Through Deep Time | NCT06381531 | Brain Tumor Oncology | Imaging with CT... | - | Tata Memorial Centre | |
Survival Monitoring in Russian Cancer Registries | NCT06043947 | Melanoma Breast Cancer Oncology Colon Cancer Prostate Cancer Survivorship Lung Cancer Cervix Cancer | 0 Years - 100 Years | N.N. Petrov National Medical Research Center of Oncology | ||
A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments | NCT05152472 | Unresectable Ga... Locally Advance... Metastatic Gast... | Atezolizumab 12... Imatinib 400 MG | 18 Years - | Centre Leon Berard | |
Couple-Based Intervention for Patients With Head and Neck Cancer and Their Partners | NCT01785576 | Head and Neck C... | Couple-Based CB... | 18 Years - | NorthShore University HealthSystem | |
The Effectiveness of "Multi-Psychological Empowerment" Courses | NCT05977504 | Cancer Oncology Psychological Self Efficacy Communication | Multi-Psycholog... | 20 Years - | National Taiwan University Hospital | |
Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging | NCT05254132 | Non Small Cell ... | Liquid biopsy | 18 Years - | OncoRadiomics | |
CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology | NCT03302767 | Cancer | Psychological a... | 25 Years - 55 Years | Institut Bergonié | |
A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia | NCT02016729 | Advanced Malign... Cancer Oncology Oncology Patien... Acute Myeloid L... | AMG 232 Trametinib | 18 Years - | Kartos Therapeutics, Inc. | |
Digital Intervention for the Modification of Lifestyles (iGame) | NCT04019119 | Low Back Pain Oncology Depression Sedentary Lifes... Sedentary Behav... | Digital interve... | 18 Years - 65 Years | University of Malaga | |
The 1st Tumor CytokinoTherapy Database (TCTD-1) | NCT06222801 | Oncology | Tumor necrosis ... Interferon gamm... | 18 Years - 95 Years | OncoCareClinic 308 Ltd | |
Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders | NCT03147599 | Oncology Incontinence Incontinence, D... Incontinence, N... Bladder Cancer Orthotopic Neob... | Coloverin Placebo | 18 Years - | Mansoura University | |
Intelligent Electric Bicycle for Health (VELIS) to Optimize the Return to Physical Activity for Oncology Patients | NCT03340857 | Cancer Oncology | Intelligent ele... | 18 Years - | Fondation Audavie | |
Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer | NCT00322400 | Locally Recurre... | Docetaxel Paclitaxel AMG 706 | 18 Years - | Amgen | |
A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer | NCT00274469 | Metastatic Brea... | fulvestrant anastrozole | 45 Years - 100 Years | AstraZeneca | |
Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects | NCT01517399 | Solid Tumors | tivantinib omeprazole s-warfarin caffeine vitamin K digoxin midazolam | 18 Years - | Daiichi Sankyo | |
Robotic Radical Cystectomy Outcomes | NCT04900558 | Bladder Cancer Muscle-Invasive... Oncology Recurrence Surgery | Radical Cystect... | 18 Years - | University of Florence | |
Personalized Functional Profiling in Metastatic Gastrointestinal Cancer or Recurrent Glioblastoma Patients in Luxembourg. | NCT03997617 | Oncology | Personalized Fu... | 18 Years - | Luxembourg Institute of Health | |
A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients | NCT06010342 | Solid Tumor | TL118 Capsule | 18 Years - | Teligene US | |
Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status | NCT02835937 | Red Blood Cell ... Anemia Hematology Oncology Ambulatory Care | No-Transfuse | 18 Years - | Mayo Clinic | |
Music Breathing for Caregivers of Children Newly Diagnosed With Cancer | NCT06052904 | Oncology Psychological D... | mHealth-deliver... Online educatio... | - | Chinese University of Hong Kong | |
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg | NCT00305448 | Advanced Breast... Metastatic Brea... | Fulvestrant Fulvestrant | - | AstraZeneca | |
Evaluation of Low Flow and Normal Flow Anesthesia Management in Robotic Assisted Laparoscopic Surgeries | NCT06430593 | Oncology | low-flow anesth... | 18 Years - 75 Years | Başakşehir Çam & Sakura City Hospital | |
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors | NCT05704985 | Cancer Solid Tumor Colorectal Canc... Pancreas Cancer Non Small Cell ... Head and Neck C... Gynecologic Can... Skin Cancer Kidney Cancer | DK210 (EGFR) Radiation thera... Immune checkpoi... Chemotherapy | 18 Years - | DEKA Biosciences |